223 related articles for article (PubMed ID: 30966759)
21. Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Gerretsen P; Iwata Y; Graff-Guerrero A;
J Geriatr Psychiatry Neurol; 2016 May; 29(3):149-59. PubMed ID: 26400248
[TBL] [Abstract][Full Text] [Related]
22. Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.
Pereira JB; Strandberg TO; Palmqvist S; Volpe G; van Westen D; Westman E; Hansson O;
Cereb Cortex; 2018 Jan; 28(1):340-349. PubMed ID: 29136123
[TBL] [Abstract][Full Text] [Related]
23. Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's disease.
Park JC; Han SH; Lee H; Jeong H; Byun MS; Bae J; Kim H; Lee DY; Yi D; Shin SA; Kim YK; Hwang D; Lee SW; Mook-Jung I
Prog Neurobiol; 2019 Dec; 183():101690. PubMed ID: 31605717
[TBL] [Abstract][Full Text] [Related]
24. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.
Chiotis K; Carter SF; Farid K; Savitcheva I; Nordberg A;
Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1492-506. PubMed ID: 26130168
[TBL] [Abstract][Full Text] [Related]
25. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
[TBL] [Abstract][Full Text] [Related]
26. Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.
Guo T; Brendel M; Grimmer T; Rominger A; Yakushev I;
J Nucl Med; 2017 Apr; 58(4):639-645. PubMed ID: 27754901
[TBL] [Abstract][Full Text] [Related]
27. Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.
Leuzy A; Zimmer ER; Heurling K; Rosa-Neto P; Gauthier S
Amyloid; 2014 Sep; 21(3):143-8. PubMed ID: 24919109
[TBL] [Abstract][Full Text] [Related]
28.
Ottoy J; Verhaeghe J; Niemantsverdriet E; De Roeck E; Wyffels L; Ceyssens S; Van Broeckhoven C; Engelborghs S; Stroobants S; Staelens S
Alzheimers Dement; 2019 Sep; 15(9):1172-1182. PubMed ID: 31405824
[TBL] [Abstract][Full Text] [Related]
29. Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir.
Hornberger J; Bae J; Watson I; Johnston J; Happich M
Curr Med Res Opin; 2017 Apr; 33(4):675-685. PubMed ID: 28035842
[TBL] [Abstract][Full Text] [Related]
30. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
31. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
32. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
33. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
34. Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
Walden LM; Hu S; Madabhushi A; Prescott JW;
J Alzheimers Dis; 2021; 83(1):423-433. PubMed ID: 34334397
[TBL] [Abstract][Full Text] [Related]
35. Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage.
Asken BM; Elahi FM; La Joie R; Strom A; Staffaroni AM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Karydas A; Wang P; Rojas JC; Boxer AL; Miller BL; Rabinovici GD; Kramer JH; Casaletto KB
J Alzheimers Dis; 2020; 78(1):265-276. PubMed ID: 32986672
[TBL] [Abstract][Full Text] [Related]
36. Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.
Kikukawa T; Abe T; Ataka S; Saito H; Hasegawa I; Mino T; Takeuchi J; Kawabe J; Wada Y; Watanabe Y; Itoh Y
Neurol Sci; 2018 Sep; 39(9):1597-1602. PubMed ID: 29936556
[TBL] [Abstract][Full Text] [Related]
37. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
[TBL] [Abstract][Full Text] [Related]
38. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
[TBL] [Abstract][Full Text] [Related]
39. Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset.
Tateno A; Sakayori T; Higuchi M; Suhara T; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 Jul; 30(7):720-8. PubMed ID: 25335941
[TBL] [Abstract][Full Text] [Related]
40. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
